Medicare Enrolled
Dr. William Reilly, M.D.
Interventional Cardiology · Waterloo, IL
Practice pattern: Remote & Cardiac
— Practice combining remote and cardiac services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Reilly from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Reilly?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Reilly
Dr. William Reilly is an interventional cardiology specialist in Waterloo, IL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Reilly performed 3,357 Medicare services across 1,337 unique beneficiaries.
Between the years covered by Open Payments, Dr. Reilly received a total of $7,882 from 31 pharmaceutical and/or device companies across 202 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Reilly is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 25% volume in IL
$7,882 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,357
Medicare services
Top 25% in IL for interventional cardiology
1,337
Unique beneficiaries
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~177 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
716 | $53 | $678 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
613 | $20 | $109 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
432 | $42 | $140 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
225 | $16 | $98 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
215 | $359 | $463 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
191 | $22 | $124 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
191 | $140 | $802 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
132 | $17 | $136 |
| Exercise or drug-induced heart stress test with ECG A test that monitors the heart's electrical activity while the patient exercises or receives medication to increase heart rate. |
132 | $21 | $137 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
132 | $11 | $124 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
107 | $19 | $69 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
69 | $141 | $784 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
51 | $10 | $95 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
38 | $29 | $155 |
| Cardiac catheterization | 33 | $219 | $940 |
| Ultrasound of leg arteries at rest and after exercise This test uses sound waves to create images of the blood vessels in the legs while the patient is resting and after physical activity to assess blood flow. |
33 | $108 | $523 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
22 | $99 | $207 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
14 | $51 | $286 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
11 | $19 | $96 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
20.2% high complexity
34.8% medium
45.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,882
Total received (2018-2024)
Avg $1,126/year across 7 years
Top 40% in IL for interventional cardiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
202
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,869 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$236
2023
$237
2022
$1,484
2021
$639
2020
$395
2019
$3,893
2018
$998
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
BIOTRONIK INC.
$122
Philips North America LLC
$66
GE HEALTHCARE
$30
Novartis Pharmaceuticals Corporation
$18
Top 3 companies account for 92.4% of 2024 payments
All-time payments by company (2018-2024) ›
BIOTRONIK INC.
$3,967
Amgen Inc.
$666
Janssen Pharmaceuticals, Inc
$651
Boston Scientific Corporation
$490
Philips Electronics North America Corporation
$319
Impulse Dynamics (USA) Inc.
$193
BOSTON SCIENTIFIC CORPORATION
$167
Novartis Pharmaceuticals Corporation
$147
Watermark Medical, Inc.
$147
Abbott Laboratories
$141
ARALEZ PHARMACEUTICALS US INC.
$124
Cardinal Health 200, LLC
$95
SANOFI-AVENTIS U.S. LLC
$93
E.R. Squibb & Sons, L.L.C.
$90
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$77
Philips North America LLC
$66
Allergan Inc.
$64
CVRx, Inc.
$62
GE HEALTHCARE
$53
Boehringer Ingelheim Pharmaceuticals, Inc.
$46
Cardiovascular Systems Inc.
$39
Siemens Medical Solutions USA, Inc.
$30
AstraZeneca Pharmaceuticals LP
$29
ABIOMED
$20
Medtronic Vascular, Inc.
$18
Merck Sharp & Dohme LLC
$16
Gilead Sciences, Inc.
$15
AngioDynamics, Inc.
$14
iRhythm Technologies, Inc.
$14
Bayer HealthCare Pharmaceuticals Inc.
$14
Regeneron Healthcare Solutions, Inc.
$12
Top 3 companies account for 67.0% of all-time payments
Associated products mentioned in payments ›
(5027) Intact Vascular Und · (6554) Periph Vasc Undiv · (6554) Peripheral Vascular Undivided · (6586) Pioneer · (9284) Stellarex · (BK5) Azurion 5 M20 · ACUSON Sequoia Diagnostic Ultrasound System · ANGIOJET · ARES HOME SLEEP TESTING DEVICE · Acticor · Acticor 7 VR-T DX · Adempas · Allure Quadra RF CRT Pacemaker · Assurity Pacemaker · BIOMONITOR · BRILINTA · BYSTOLIC · Barostim Neo System · Corlanor · Durata Defibrillation ICD Lead · ELIQUIS · ENTRESTO · EPIC VASCULAR · Edora · GENERAL ATHERECTOMY · GENERAL STENTS · GENERAL METALLIC STENTS · GENERAL VASCULAR INTERVENTION · GENERAL ATHERECTOMY · General - Atherectomy · HawkOne · ILAB · INNOVA · Image Guided Therapy Devices _ Peripheral · Impella · JARDIANCE · JETSTREAM · JETSTREAM SC · LEQVIO · LifeVest · OPTIMIZER · Optimizer · Orsiro Mission · PK Papyrus · PRADAXA · PRALUENT · Pacemakers · Peripheral Orbital Atherectomy System · Pulsar-18 T3 · ROTAPRO · Repatha · Stellarex · VERQUVO · VRAYLAR · WALLSTENT · XARELTO · ZIO Patch · ZONTIVITY · Zero Gravity
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Interventional cardiologists within 10 mi
16
Per 100K population
45.8
County median income
$101,635
Nearest hospital
RED BUD REGIONAL HOSPITAL
11.2 mi
11.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Reilly is a remote & cardiac specialist, with above-average Medicare volume (top 25% in IL), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Reilly experienced with remote monitoring of implantable heart rhythm device?
Based on Medicare claims data, Dr. Reilly performed 716 remote monitoring of implantable heart rhythm device services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Reilly receive payments from pharmaceutical companies?
Yes. Dr. Reilly received a total of $7,882 from 31 companies across 202 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Reilly's costs compare to other interventional cardiologists in Waterloo?
Dr. Reilly's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Reilly) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in Waterloo
Browse interventional cardiologists in Waterloo ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in IL
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in IL
Which IL interventional cardiologists receive the most from drug and device companies.
By company
BIOTRONIK INC. Payments to Doctors
See all physicians who received payments from BIOTRONIK INC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology